TTR p.Thr139Met
Variant summary
The NM_000371.4(TTR):c.416C>T (p.Thr139Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene TTR is a tumor suppressor gene (CancerMine: 1 TSG, 1 oncogene citations). The gene TTR is a known oncogene (CancerMine: 1 TSG, 1 oncogene citations). The variant allele was found at a cumulative frequency of 0.0027 (AC=4,364) in the gnomAD database across 1,614,166 control chromosomes, including 6 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.0034. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (no review stars). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.T139= (synonymous): Conflicting_classifications_of_pathogenicity (ClinVar VariationId 43455) The variant has been observed in cBioPortal in 5 samples across 5 studies and 4 cancer types; somatic enrichment level: SUPPORTING (Observed repeatedly in cBioPortal somatic datasets.). This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_000371.4 missense
Scores
Clinical Significance
Conservation
Publications
- amyloidosis, hereditary systemic 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia
- familial amyloid neuropathyInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
- hereditary ATTR amyloidosisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- carpal tunnel syndrome 1Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
- heart conduction diseaseInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- ATTRV122I amyloidosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 5 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O4Enriched in somatic variant database | Enriched in cBioPortal (pre-computed score ≥ 1.0) — Supporting (O4); cBioPortal: samples=5 | studies=5 | cancer types=4 | level=SUPPORTING | points=1.0 | reason: Observed repeatedly in cBioPortal somatic datasets. | ||
| O6Computational evidence supports deleterious effect | Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect | ||
| O7Mutational hotspot or critical domain | Moderate: ≥10 same AA change, or strong functional domain signal; No cancerhotspots.org hit at this position; UniProt domain: 146 pathogenic, 10 benign (OR vs. background: 69.8).; ±8 AA neighbourhood: 9 pathogenic, 2 benign (OR vs. background: 19.0); Variant does not impact splicing — splice-hotspot path not applicable | ||
| O8Missense constraint in gene or region | Missense in gene/domain constrained for missense variation where missense is common disease mechanism (O8 supporting); Gene/disease mechanism: missense is a common mechanism of oncogenesis; gnomAD missense Z-score: 1.55 (threshold ≥3.09 for constraint); Domain-level constraint: variant is in a critically constrained functional domain (IS_AT_CRITICAL_DOMAIN) |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000371.4. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
TTR | TSL:1MANE Select | c.416C>T p.Thr139Met | missense | Exon 4 of 4 | Prot: ENSP00000237014.4 UniProt: | |
TTR | c.416C>T p.Thr139Met | missense | Exon 6 of 6 | Prot: ENSP00000497927.1 UniProt: | ||
TTR | c.416C>T p.Thr139Met | missense | Exon 6 of 6 | Prot: ENSP00000529047.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.00172 | AC:261 | Hom:0 | AN:152180 | Cov:32 |
GnomAD2 exomes | AF: 0.00151 | AC:379 | AN:251440 | ||
GnomAD4 exome | AF: 0.00281 | AC:4103 | Hom:6 | AN:1461868 | Cov:31 |
GnomAD4 genome | AF: 0.00171 | AC:261 | Hom:0 | AN:152298 | Cov:32 |
TOPMed (Bravo) | AF: 0.00170 | AC:449 | Hom:0 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.00228 | AC:1102 | Hom:4 | AN:484088 | |
Local & regional cohorts 6 sources | |||||
ABraOM SABE-WGS-1171 | AF: 0.00128 | AC:3 | Hom:0 | AN:2342 | |
ESP6500 (Exome Variant Server) | AF: 0.00223 | AC:29 | AN:13006 | ||
ToMMo 61KJPN (+60KJPN MNV) | AF: 0.00 | AC:0 | Hom:0 | AN:122732 | |
Turkish Variome | AF: 0.000298 | AC:2 | Hom:0 | AN:6718 | |
UK10K | AF: 0.00450 | AC:34 | AN:7562 | ||
WBBC (Westlake BioBank for Chinese) pilot | AF: 0.000112 | AC:1 | Hom:0 | AN:8960 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
ASC | 0.00225 * | 25 | 11108 | 0.00278 * | 49 | 17618 |
BipEx | 0.00419 | 119 | 28420 | 0.00288 | 83 | 28844 |
Epi25 | 0.00219 | 92 | 41958 | 0.00260 | 174 | 66886 |
SCHEMA | 0.00133 | 162 | 121726 | 0.00161 | 307 | 190572 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 24 | |
AlphaMissense | Uncertain | 0.43 | |
BayesDel_addAF | Pathogenic | 0.16 | D |
BayesDel_noAF | Pathogenic | 0.46 | |
CADD | Pathogenic | 26 | |
DANN | Pathogenic | 1.0 | |
DEOGEN2 | Pathogenic | 0.85 | D |
Eigen | Pathogenic | 0.86 | |
Eigen_PC | Pathogenic | 0.80 | |
FATHMM_MKL | Pathogenic | 0.97 | D |
GPN-Star LLR | N/A | -6.5 | |
GPN-Star score | N/A | 6.5 | |
LIST_S2 | Uncertain | 0.96 | D |
M_CAP | Pathogenic | 0.68 | D |
MetaRNN | Benign | 0.050 | T |
MetaSVM | Pathogenic | 0.90 | D |
Mutation Taster | N/A | 34/66 | disease causing |
MutationAssessor | Pathogenic | 3.3 | M |
PhyloP100 | Uncertain | 6.1 | |
popEVE | Benign | -4.5 | |
PrimateAI | Benign | 0.48 | T |
PROVEAN | Benign | -2.0 | N |
RBP_binding_hub_radar | N/A | 0.0 | |
RBP_regulation_power_radar | N/A | 1.7 | |
REVEL | Pathogenic | 0.68 | |
Sift | Uncertain | 0.0090 | D |
Sift4G | Uncertain | 0.0040 | D |
Varity_R | N/A | 0.42 | |
VESM-3B | Benign | -9.3 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.